Technologies for Identifying Short-lived Proteins

Information

  • Research Project
  • 6401746
  • ApplicationId
    6401746
  • Core Project Number
    R43GM064036
  • Full Project Number
    1R43GM064036-01
  • Serial Number
    64036
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/2001 - 24 years ago
  • Project End Date
    9/29/2002 - 23 years ago
  • Program Officer Name
    IKEDA, RICHARD A.
  • Budget Start Date
    9/30/2001 - 24 years ago
  • Budget End Date
    9/29/2002 - 23 years ago
  • Fiscal Year
    2001
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/26/2001 - 24 years ago
Organizations

Technologies for Identifying Short-lived Proteins

Most regulatory proteins turn over rapidly. We will develop an innovative technology to identify labile proteins, using libraries of proteins fused to green fluorescent protein (GFP) to monitor protein degradation. We will make GFP-cDNA expression libraries by fusing cDNA downstream from the C terminus of GFP. GFP can be detected in real time in living cells without disrupting the cells. We will identify cells expressing short-lived proteins by selecting for appropriate time- dependent changes in cellular fluorescence. Cells with the desired characteristics will be isolated and subjected to gene recovery and sequence analysis. The transfected cDNAs in those cells will be recovered, cloned and sequenced and, after analysis and annotation, established as a database. We anticipate that the transcripts from most of the genes we expect to identify will be highly regulated. A microarray of these genes provides an efficient way to examine the changes of their transcripts under different physiological conditions. We will commercialize the gene clones, expression cell lines and bioinformatic database as well as related reagents. PROPOSED COMMERCIAL APPLICATIONS: Labile proteins usually have important regulatory roles in cells. We will develop a general method to reveal labile proteins and will market the information and products thus produced. In addition to constitutively labile proteins, we will identify proteins whose degradation is induced by specific conditions in specific cells. The possible combinations of proteins, cells and inciting agents are effectively limitless. These products will therefore enjoy a durable and sizeable market.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    140000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:140000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PANOMICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    REDWOOD CITY
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94063
  • Organization District
    UNITED STATES